Publications by authors named "Angela Crook"

Claim this Profile
E
Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial.
Nicholas I Paton, Christopher Cousins, Intan P Sari, Erlina Burhan, Nan-Kai Ng, Angela M Crook

Lancet Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical and Occupational Therapy Utilization After Infant Abdominal Surgery.
Sindhu V Mannava, Eamaan Turk, Attie Vogler, Angela Crook, Mackenzie McQuay

Phys Occup Ther Pediatr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing a response-over-continuous-intervention (ROCI) randomised trial: Implementation in the Phase 2C part (duration ranging) of the PARADIGM4TB trial.
Tra My Pham, Angela M Crook, Katie Rolfe, Patrick P J Phillips, Suzanne M Dufault

Contemp Clin Trials· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal dosing and duration of linezolid for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis: an individual patient data meta-analysis.
Nakwon Kwak, Joong-Yub Kim, Areum Han, Catherine Berry, Maria Beumont, Angela Crook

Eur Respir J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of shortened intensive treatment for children with tuberculous meningitis (SURE): a protocol for a phase 3 randomised controlled trial evaluating 6 months of antituberculosis therapy and 8 weeks of aspirin in Asian and African children with tuberculous meningitis.
Julie Huynh, Chishala Chabala, Suvasini Sharma, Louise Choo, Varinder Singh, Angela Crook

BMJ Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
Muge Cevik, Lindsay C Thompson, Caryn Upton, Valéria Cavalcanti Rolla, Mookho Malahleha, Angela M Crook

Lancet Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target regimen profiles for tuberculosis treatment.
Christian Lienhardt, Kelly E Dooley, Payam Nahid, Charles Wells, Theresa S Ryckman, Angela Crook

Bull World Health Organ· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE Trial.
Chishala Chabala, Eric Wobudeya, Marieke M van der Zalm, Monica Kapasa, Priyanka Raichur, Angela Crook

Clin Infect Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-wave morphology abnormalities in the STREAM stage 1 trial.
Gareth Hughes, William J Young, Henry Bern, Angela Crook, Pier D Lambiase

Expert Opin Drug Saf· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A flexible multi-metric Bayesian framework for decision-making in Phase II multi-arm multi-stage studies.
Suzanne M Dufault, Angela M Crook, Katie Rolfe, Patrick P J Phillips

Stat Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV.
Chishala Chabala, Anna Turkova, Monica Kapasa, Kristen LeBeau, Chimuka H Tembo, Angela Crook

Pediatr Infect Dis J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
Nicholas I Paton, Christopher Cousins, Celina Suresh, Erlina Burhan, Ka Lip Chew, Angela M Crook

N Engl J Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regimens for Drug-Resistant Tuberculosis. Reply.
Juliano Timm, Angela M Crook, Eugene Sun

N Engl J Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking intercurrent events in defining estimands for tuberculosis trials.
Tra My Pham, Conor D Tweed, James R Carpenter, Brennan C Kahan, Andrew J Nunn, Angela M Crook

Clin Trials· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
Francesca Conradie, Tatevik R Bagdasaryan, Sergey Borisov, Pauline Howell, Lali Mikiashvili, Angela M Crook

N Engl J Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial.
Molebogeng X Rangaka, Yohhei Hamada, Trinh Duong, Henry Bern, Joanna Calvert, Angela Crook

BMJ Open· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.
Anna Turkova, Genevieve H Wills, Eric Wobudeya, Chishala Chabala, Megan Palmer, Angela M Crook

N Engl J Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings.
Nurulamin M Noor, Sarah L Pett, Hanif Esmail, Angela M Crook, Claire L Vale

F1000Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of Xpert Ultra in Diagnosis of Pulmonary Tuberculosis among Children in Uganda: a Substudy from the SHINE Trial.
Willy Ssengooba, Jean de Dieu Iragena, Lydia Nakiyingi, Serestine Mujumbi, Eric Wobudeya, Angela M Crook

J Clin Microbiol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. Reply.
Francesca Conradie, Daniel Everitt, Angela M Crook

N Engl J Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.
Francesca Conradie, Andreas H Diacon, Nosipho Ngubane, Pauline Howell, Daniel Everitt, Angela M Crook

N Engl J Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial.
Conor D Tweed, Rodney Dawson, Divan A Burger, Almari Conradie, Angela M Crook

Lancet Respir Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status.
Conor D Tweed, Angela M Crook, Rodney Dawson, Andreas H Diacon, Timothy D McHugh

BMC Pulm Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions.
Cecilia L Moore, Wolfgang Stöhr, Angela M Crook, Laura Richert, Jean-Daniel Leliévre

Lancet HIV· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP).
James A Seddon, Anthony J Garcia-Prats, Susan E Purchase, Muhammad Osman, Anne-Marie Demers, Angela M Crook

Trials· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis